Mengrou Lu

1.2k total citations
23 papers, 937 citations indexed

About

Mengrou Lu is a scholar working on Molecular Biology, Biomedical Engineering and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mengrou Lu has authored 23 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mengrou Lu's work include Advanced biosensing and bioanalysis techniques (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and RNA Interference and Gene Delivery (3 papers). Mengrou Lu is often cited by papers focused on Advanced biosensing and bioanalysis techniques (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and RNA Interference and Gene Delivery (3 papers). Mengrou Lu collaborates with scholars based in United States, China and Australia. Mengrou Lu's co-authors include Siyang Zheng, Weian Zhao, Yaxuan Liang, Brandon M. Lehrich, Louai Labanieh, M. Monsur Ali, Jinping Liu, Samir M. Iqbal, Haitao Ma and Mohammed Arif I. Mahmood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Journal of Biological Chemistry.

In The Last Decade

Mengrou Lu

23 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengrou Lu United States 12 670 211 137 120 96 23 937
Misu Lee South Korea 18 417 0.6× 143 0.7× 177 1.3× 194 1.6× 65 0.7× 59 961
May Zaw Thin United Kingdom 16 343 0.5× 202 1.0× 179 1.3× 124 1.0× 49 0.5× 21 797
Sara Pignatta Italy 15 332 0.5× 211 1.0× 313 2.3× 98 0.8× 63 0.7× 26 816
Xiaoyang Zheng United States 11 472 0.7× 87 0.4× 151 1.1× 72 0.6× 61 0.6× 15 863
Larissa Lezina United Kingdom 14 679 1.0× 104 0.5× 222 1.6× 124 1.0× 49 0.5× 20 1.0k
Varvara V. Dudenkova Russia 20 426 0.6× 404 1.9× 105 0.8× 153 1.3× 49 0.5× 77 1.2k
Xishan Chen China 18 601 0.9× 202 1.0× 211 1.5× 91 0.8× 70 0.7× 32 1.0k
Calvin R. Justus United States 9 530 0.8× 169 0.8× 211 1.5× 206 1.7× 34 0.4× 10 1.0k
Michal Stark Israel 18 627 0.9× 101 0.5× 279 2.0× 147 1.2× 33 0.3× 31 1.1k
Meysam Yousefi Iran 18 650 1.0× 200 0.9× 241 1.8× 232 1.9× 26 0.3× 28 1.0k

Countries citing papers authored by Mengrou Lu

Since Specialization
Citations

This map shows the geographic impact of Mengrou Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengrou Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengrou Lu more than expected).

Fields of papers citing papers by Mengrou Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengrou Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengrou Lu. The network helps show where Mengrou Lu may publish in the future.

Co-authorship network of co-authors of Mengrou Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengrou Lu. A scholar is included among the top collaborators of Mengrou Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengrou Lu. Mengrou Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawson, Harrison, Nguyễn Huy Hoàng, Mengrou Lu, et al.. (2025). Synthetic Strategy for mRNA Encapsulation and Gene Delivery with Nanoscale Metal‐Organic Frameworks. Advanced Functional Materials. 35(44). 4 indexed citations
2.
Lu, Mengrou, et al.. (2023). Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing. Cell Reports Medicine. 4(10). 101227–101227. 1 indexed citations
3.
Zhang, Yan, Faming Wang, Lai Shi, et al.. (2023). Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy. Journal of Controlled Release. 354. 196–206. 20 indexed citations
4.
Milošević, Jadranka, Mengrou Lu, Wallace Greene, Hong‐Zhang He, & Siyang Zheng. (2021). An Ultrafast One-Step Quantitative Reverse Transcription–Polymerase Chain Reaction Assay for Detection of SARS-CoV-2. Frontiers in Microbiology. 12. 749783–749783. 4 indexed citations
5.
Lu, Mengrou, et al.. (2021). The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Autoimmune Disorders. Frontiers in Immunology. 12. 566299–566299. 51 indexed citations
6.
Liang, Yaxuan, Brandon M. Lehrich, Siyang Zheng, & Mengrou Lu. (2021). Emerging methods in biomarker identification for extracellular vesicle‐based liquid biopsy. Journal of Extracellular Vesicles. 10(7). e12090–e12090. 124 indexed citations
7.
Rivera, Victor M., Wei‐Sheng Huang, Mengrou Lu, et al.. (2021). Abstract 1292: Preclinical characterization of THE-630, a next-generation inhibitor for KIT-mutant gastrointestinal stromal tumors (GIST). Cancer Research. 81(13_Supplement). 1292–1292. 7 indexed citations
8.
Wu, Haiya, et al.. (2018). Determination and pharmacokinetics and bioavailability of O-demethyl nuciferine in mice by UPLC–MS/MS. Acta Chromatographica. 31(3). 222–227. 4 indexed citations
9.
Nguyen, Duc, William Pandori, Sharmila Mallya, et al.. (2017). mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph+ and Ph-like B-ALL. Molecular Cancer Therapeutics. 16(9). 1942–1953. 11 indexed citations
10.
Liu, Linan, Shirley X. Zhang, Wenbin Liao, et al.. (2017). Mechanoresponsive stem cells to target cancer metastases through biophysical cues. Science Translational Medicine. 9(400). 78 indexed citations
11.
Zhou, Yunfang, Mengrou Lu, Jie Weng, et al.. (2017). Serum metabolic changes in rats of acute paraquat poisoning treated by pirfenidone. 10(4). 6656–6663. 2 indexed citations
12.
Zhang, Kaixiang, M. Monsur Ali, Linan Liu, et al.. (2015). Digital quantification of miRNA in blood using integrated comprehensive droplet digital detection (IC3D) system. 200–202. 1 indexed citations
13.
14.
Liu, Linan, Shirley X. Zhang, Wenbin Liao, et al.. (2015). Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay. Stem Cell Research & Therapy. 6(1). 181–181. 7 indexed citations
15.
Wang, Xianqin, Shuanghu Wang, Jianshe Ma, et al.. (2015). Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 115. 368–374. 52 indexed citations
16.
Zhang, Kaixiang, M. Monsur Ali, Linan Liu, et al.. (2015). Digital quantification of miRNA directly in plasma using integrated comprehensive droplet digital detection. Lab on a Chip. 15(21). 4217–4226. 56 indexed citations
17.
Wiraja, Christian, David Yeo, Daniel Chin Shiuan Lio, et al.. (2014). Aptamer technology for tracking cells’ status & function. PubMed Central. 2(1). 33–33. 16 indexed citations
18.
Nguyen, Duc, Sharmila Mallya, Sarah Tang, et al.. (2014). mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells. Oncotarget. 6(4). 2088–2100. 29 indexed citations
19.
Vo, Thanh‐Trang, et al.. (2014). Abstract B24: Inhibition of mTOR induces multidrug resistance in B-progenitor acute lymphocytic leukemia. Cancer Research. 74(20_Supplement). B24–B24. 1 indexed citations
20.
So, Lomon, Sung Su Yea, Jean Oak, et al.. (2012). Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function*. Journal of Biological Chemistry. 288(8). 5718–5731. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026